Excel Diagnostics and Nuclear Oncology Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Prostate cancer4 trials
• Neuroendocrine tumours1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Completed2 trials

Lead sponsor

• Curium US LLC2 trials
• ABX advanced biochemical compounds GmbH1 trial
• Fusion Pharmaceuticals Inc.1 trial
• Orano Med LLC1 trial

Running trials

• Active, not recruiting

  Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

  NCT06235151· Phase 3· Curium US LLC· Source

• Active, not recruiting

  Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients

  NCT05153772· Phase 2· Orano Med LLC· Source

• Active, not recruiting

  Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).

  NCT05219500· Phase 2· Fusion Pharmaceuticals Inc.· Source

Closed trials

• Completed

  Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

  NCT06235099· Phase 3· Curium US LLC· Source

• Completed

  Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

  NCT04742361· Phase 3· ABX advanced biochemical compounds GmbH· Source